UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort

Celli, B; Locantore, N; Yates, JC; Bakke, P; Calverley, PMA; Crim, C; Coxson, HO; ... Evaluation of COPD Longitudinally to Identify Predictive Surroga; + view all (2020) Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. European Respiratory Journal 10.1183/13993003.01339-2020. (In press).

[thumbnail of Lomas_ECLIPSE 8 year mortality - R2 v20200616 - clean.pdf] Text
Lomas_ECLIPSE 8 year mortality - R2 v20200616 - clean.pdf - Accepted version
Access restricted to UCL open access staff until 11 December 2021.

Download (722kB)

Abstract

RATIONALE: There are no validated measures of disease activity in chronic obstructive pulmonary disease (COPD). Since "active" disease is expected to have worse outcomes (e.g. mortality), we explored potential markers of disease activity in patients enrolled in the ECLIPSE cohort in relation to 8-year all-cause mortality. METHODS: We investigated: (1) how changes in relevant clinical variables over time (1 or 3 years) relate to 8-year mortality; (2) whether these variables inter-relate; and (3) if any clinical, imaging, and/or biological marker measured cross-sectionally at baseline relates to any activity component. RESULTS: Results showed that: (1) After 1 year, hospitalisation for COPD, exacerbation frequency, worsening of body mass index, airflow obstruction, dyspnoea, and exercise (BODE) index or health status (St. George's Respiratory Questionnaire [SGRQ]), and persistence of systemic inflammation were significantly associated with 8-year mortality; (2) At 3 years, the same markers, plus forced expiratory volume in 1 s (FEV1) decline and to a lesser degree computed tomography (CT) emphysema, showed association, thus qualifying as markers of disease activity; (3) Changes in FEV1, inflammatory cytokines and CT emphysema were not inter-related, while the multidimensional indices (BODE and SGRQ) showed modest correlations; and, (4) Changes in these markers could not be predicted by any baseline cross-sectional measure. CONCLUSIONS: In COPD, 1- and 3-year changes in exacerbation frequency, systemic inflammation, BODE and SGRQ scores, and FEV1 decline are independent markers of disease activity associated with 8-year all-cause mortality. These disease activity markers are generally independent and not predictable from baseline measurements.

Type: Article
Title: Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Location: England
DOI: 10.1183/13993003.01339-2020
Publisher version: https://erj.ersjournals.com/content/early/2020/06/...
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > VP: Health
URI: https://discovery.ucl.ac.uk/id/eprint/10117545
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item